US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Celularity Inc. Warrant

0.0067

-0.0023-25.56%

Volume:600.00

Turnover:4.02

Market Cap:160.46K

PE:0.00

High:0.0067

Open:0.0067

Low:0.0067

Close:0.0090

52wk High:0.7511

52wk Low:0.0065

Shares:23.95M

Float Shares:23.95M

Volume Ratio:0.06

T/O Rate:0.00%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.3352

ROE:-6367.24%

ROA:-25.03%

PB:-0.01

PE(LYR):- -

Loading ...

Overview Company News Filings

BRIEF-Celularity Receives $12.2 Million From Sale Of New Jersey Net Operating Losses

Celularity Announces Peer-Reviewed Publication of Phase 2 Clinical Trial Results Demonstrating the Safety and Efficacy of Human Placenta-Derived Cells (Pda-002) for Diabetic Foot Ulcers Complicated by Peripheral Artery Disease

THOMSON REUTERS

BRIEF-Celularity Receives Nasdaq Notice Regarding Form 10-Q

BRIEF-Celularity Completes Major Balance Sheet Restructuring

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CELUW/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"CELUW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CELUW\",,,,,undefined,":{"symbol":"CELUW","market":"US","secType":"STK","nameCN":"Celularity Inc. Warrant","latestPrice":0.0067,"timestamp":1771880400000,"preClose":0.009,"halted":0,"volume":600,"delay":0,"changeRate":-0.2555555555555555,"floatShares":23949233,"shares":23949233,"eps":-3.3352,"marketStatus":"Not Yet Opened","change":-0.0023,"latestTime":"02-23 16:00:00 EST","open":0.0067,"high":0.0067,"low":0.0067,"amount":4.02,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-3.3352,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771923600000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":0.009,"volumeRatio":0.061642},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CELUW\",,,,,undefined,":{"symbol":"CELUW","floatShares":23949233,"roa":"-25.03%","roe":"-6367.24%","lyrEps":0,"volumeRatio":0.061642,"shares":23949233,"dividePrice":0,"high":0.0067,"amplitude":0,"preClose":0.009,"low":0.0067,"week52Low":0.0065,"pbRate":"-0.01","psRate":"0.00","week52High":0.7511,"institutionHeld":0,"latestPrice":0.0067,"eps":-3.3352,"divideRate":0,"volume":600,"delay":0,"ttmEps":-3.3352,"open":0.0067,"prevYearClose":0.01625,"prevWeekClose":0.009,"prevMonthClose":0.0093,"prevQuarterClose":0.0163,"fiveDayClose":0.007,"twentyDayClose":0.017,"sixtyDayClose":0.0273},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CELUW\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CELUW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CELUW\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CELUW\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2610762531","title":"BRIEF-Celularity Receives $12.2 Million From Sale Of New Jersey Net Operating Losses","url":"https://stock-news.laohu8.com/highlight/detail?id=2610762531","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610762531?lang=en_us&edition=fundamental","pubTime":"2026-02-10 21:52","pubTimestamp":1770731543,"startTime":"0","endTime":"0","summary":"BRIEF-Celularity Receives $12.2 Million From Sale Of New Jersey Net Operating LossesFeb 10 (Reuters) - Celularity Inc CELU.O:CELULARITY RECEIVES $12.2 MILLION FROM SALE OF NEW JERSEY NET OPERATING LOS","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nTUA9CFVW7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CELU","BK4139","CELUW"],"gpt_icon":0},{"id":"2575182492","title":"Celularity Announces Peer-Reviewed Publication of Phase 2 Clinical Trial Results Demonstrating the Safety and Efficacy of Human Placenta-Derived Cells (Pda-002) for Diabetic Foot Ulcers Complicated by Peripheral Artery Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2575182492","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575182492?lang=en_us&edition=fundamental","pubTime":"2025-10-14 20:45","pubTimestamp":1760445900,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251014:nTUABYVJBS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CELU","BK4139","CELUW"],"gpt_icon":0},{"id":"2561285714","title":"BRIEF-Celularity Receives Nasdaq Notice Regarding Form 10-Q","url":"https://stock-news.laohu8.com/highlight/detail?id=2561285714","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561285714?lang=en_us&edition=fundamental","pubTime":"2025-08-23 06:31","pubTimestamp":1755901892,"startTime":"0","endTime":"0","summary":"BRIEF-Celularity Receives Nasdaq Notice Regarding Form 10-QCelularity Inc CELU.O:CELULARITY RECEIVES NASDAQ NOTICE REGARDING FORM 10-QSource text: ID:nGNXbyxTnwFurther company coverage: CELU.O","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250822:nTUA16RLXS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CELUW","CELU"],"gpt_icon":0},{"id":"2560857851","title":"BRIEF-Celularity Completes Major Balance Sheet Restructuring","url":"https://stock-news.laohu8.com/highlight/detail?id=2560857851","media":"Reuters","labels":["corporation","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560857851?lang=en_us&edition=fundamental","pubTime":"2025-08-18 22:16","pubTimestamp":1755526578,"startTime":"0","endTime":"0","summary":"BRIEF-Celularity Completes Major Balance Sheet RestructuringAug 18 (Reuters) - Celularity Inc CELU.O:CELULARITY COMPLETES MAJOR BALANCE SHEET RESTRUCTURING, RETIRES ALL $41.6 MILLION IN SENIOR SECURED","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250818:nTUA9YR1N4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CELU","CELUW","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":4,"code":"91000000","status":"200"}]}}